Presentation OPCI 2019 The Great Debate: Intravascular Imaging is Only Beneficial in Select Cases Presenter: Bruce Samuels March 08, 2019
Presentation OPCI 2019 A case of LM iFR/FFR: When nothing works Presenter: Arnold H. Seto March 08, 2019
Presentation JIM 2019 Old And New Concepts Of Stent Guidance With Ivus And Oct Presenter: Giulio Guagliumi February 14, 2019
Presentation JIM 2019 MACE prediction: exploring IVUS+NIRS imaging and the LRP study results Presenter: Francesco Prati February 14, 2019
Presentation BIT 2019 Physiology Case Vignette : FFR Made the Diagnosis! Presenter: Afzalur Rahman February 08, 2019
Presentation BIT 2019 Practical Integration of Intravascular Imaging (IVI) and Physiology into the Cath Lab Presenter: Gary S. Mintz February 08, 2019
News Daily News EuroCTO CASTLE: Prediction Model for CTO PCI Success Shows Good Discriminating Ability L.A. McKeown February 04, 2019
Presentation CHIP Florida 2019 Summary & Conclusions: What Did We Learn? Presenter: Martin B. Leon January 26, 2019
Presentation Cardiovascular Interventions 2018 SCAD Update:What Does the Interventionalist Need to Know? Preferred Access, Advanced Imaging, Best Medical Therapy, Should We Ever Stent? Presenter: Jacqueline Saw October 26, 2018
Presentation Cardiovascular Interventions 2018 OCT, IVUS, FFR, iFR (NHPR): Which Technology When? Presenter: Ziad A Ali October 26, 2018
News Daily News Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show Michael O'Riordan October 17, 2018
News Conference News TCT 2018 Human vs Machine: Computer Algorithm Matches Experts for PCI Appropriateness and Planning Yael L. Maxwell October 11, 2018
News Daily News Two Studies Support Safety and Cost-Effectiveness of Same-Day Discharge After Elective PCI L.A. McKeown October 04, 2018
News Conference News TCT 2018 ‘Enabling Strategies’ Improve Success of Chronic Total Occlusion PCI TCT Daily Staff September 28, 2018
News Conference News TCT 2018 Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials Michael O'Riordan September 25, 2018